StonvexLoading…
StonvexStonvexStonvexCore line items from HKD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-10-31 | Annual 2024 2024-10-31 | Q4 2023 2023-10-31 | Q2 2023 2023-04-30 |
|---|---|---|---|---|
Revenue | $50.07M | $22.81M | $8.67M | $33.07M |
Operating Income | $1.12M | $37.00M | $14.34M | $153.00K |
Net Income | $96.99M | $41.67M | $30.79M | $40.81M |
EPS (Diluted) | $0.44 | $0.58 | $0.42 | $0.57 |
Total Assets | $955.36M | $502.93M | $537.50M | $483.61M |
Total Liabilities | $351.70M | $344.17M | $159.30M | $140.57M |
Cash & Equivalents | $46.36M | $60.86M | $134.84M | $152.93M |
Free Cash Flow OCF − CapEx | $14.33M | $4.09M | $21.34M | $15.50M |
Shares Outstanding | 123.77M | 76.81M | 76.65M | 74.21M |